# Aligos Therapeutics, Inc.: filings

ALGS · Nasdaq · CIK 1799448 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/algs.md) · [Financials](/companies/algs/financials.md) · [Filings](/companies/algs/filings.md) · [Insiders](/companies/algs/insiders.md)

## Reports and events: 99 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 104, 8-K 55, 3 23, SC 13G/A 22, 10-Q 18, SC 13G 17, CORRESP 11, S-8 10, SCHEDULE 13G/A 9, UPLOAD 8, 10-K 6, DEF 14A 6, DEFA14A 6, EFFECT 6, SC 13D/A 5, ARS 4, S-3 4, SCHEDULE 13G 4, D 3, SC 13D 3, 424B3 2, 424B4 2, DRS 2, PRE 14A 2, S-1 2, SEC STAFF LETTER 2, 8-A12B 1, 8-K/A 1, CERT 1, DEFR14A 1, S-1/A 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1, SC TO-C 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-15 | 16:03 ET | [8-K](/filings/0001193125-26-391880.md) | 1.01 Entry into a material agreement | 0001193125-26-391880 |
| 2026-08-06 | 08:07 ET | [10-Q](/filings/0001193125-26-336851.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336851 |
| 2026-08-06 | 08:00 ET | [8-K](/filings/0001171843-26-005294.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005294 |
| 2026-06-26 | 16:02 ET | [8-K](/filings/0001193125-26-285426.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-285426 |
| 2026-06-24 | 16:30 ET | [SCHEDULE 13D](/filings/0001193125-26-281134.md) | Ownership report, active investor | 0001193125-26-281134 |
| 2026-05-07 | 16:18 ET | [10-Q](/filings/0001193125-26-212001.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212001 |
| 2026-05-07 | 16:08 ET | [8-K](/filings/0001171843-26-003156.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003156 |
| 2026-04-29 | 16:25 ET | [DEF 14A](/filings/0001193125-26-191843.md) | Proxy statement, period 2026-06-25 | 0001193125-26-191843 |
| 2026-04-21 | 16:32 ET | [8-K](/filings/0001193125-26-166987.md) | 1.01 Entry into a material agreement | 0001193125-26-166987 |
| 2026-04-14 | 16:17 ET | [8-K](/filings/0001193125-26-154927.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-154927 |
| 2026-03-05 | 08:08 ET | [10-K](/filings/0001193125-26-092614.md) | Annual report, period 2025-12-31 | 0001193125-26-092614 |
| 2026-03-05 | 08:01 ET | [8-K](/filings/0001171843-26-001340.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001340 |
| 2026-02-04 | 16:05 ET | [8-K](/filings/0001193125-26-037558.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-037558 |
| 2025-11-06 | 08:37 ET | [10-Q](/filings/0001193125-25-268203.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268203 |
| 2025-11-06 | 08:30 ET | [8-K](/filings/0001171843-25-007075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007075 |
| 2025-08-06 | 16:13 ET | [10-Q](/filings/0000950170-25-104042.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104042 |
| 2025-08-06 | 16:06 ET | [8-K](/filings/0001171843-25-005116.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005116 |
| 2025-06-26 | 16:09 ET | [8-K](/filings/0001193125-25-148905.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-148905 |
| 2025-05-06 | 08:14 ET | [10-Q](/filings/0000950170-25-063983.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063983 |
| 2025-05-06 | 08:00 ET | [8-K](/filings/0001171843-25-002781.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002781 |
| 2025-04-28 | 16:05 ET | [DEF 14A](/filings/0001193125-25-100453.md) | Proxy statement, period 2025-06-25 | 0001193125-25-100453 |
| 2025-03-12 | 20:30 ET | [SCHEDULE 13D/A](/filings/0000950170-25-038262.md) | Ownership report, active investor, amended | 0000950170-25-038262 |
| 2025-03-10 | 08:07 ET | [10-K](/filings/0000950170-25-035929.md) | Annual report, period 2024-12-31 | 0000950170-25-035929 |
| 2025-03-10 | 08:00 ET | [8-K](/filings/0001171843-25-001352.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001352 |
| 2025-02-12 | 08:52 ET | [8-K](/filings/0001193125-25-024838.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-024838 |
| 2025-02-03 | 16:02 ET | [8-K](/filings/0001193125-25-019256.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-019256 |
| 2024-11-06 | 16:24 ET | [10-Q](/filings/0000950170-24-122371.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122371 |
| 2024-11-06 | 16:05 ET | [8-K](/filings/0001171843-24-006057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006057 |
| 2024-09-05 | 16:06 ET | [8-K](/filings/0001193125-24-214188.md) | 8.01 Other events | 0001193125-24-214188 |
| 2024-08-19 | 16:05 ET | [8-K](/filings/0001193125-24-202813.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-202813 |
| 2024-08-08 | 16:11 ET | [8-K](/filings/0001193125-24-196966.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-196966 |
| 2024-08-06 | 16:14 ET | [10-Q](/filings/0000950170-24-091828.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091828 |
| 2024-08-06 | 16:05 ET | [8-K](/filings/0001171843-24-004482.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004482 |
| 2024-06-28 | 16:00 ET | [8-K](/filings/0001193125-24-172218.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-172218 |
| 2024-05-31 | 16:05 ET | [8-K](/filings/0001193125-24-151729.md) | 3.01 Delisting notice | 0001193125-24-151729 |
| 2024-05-22 | 16:02 ET | [8-K](/filings/0001193125-24-144929.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001193125-24-144929 |
| 2024-05-15 | 17:01 ET | [8-K](/filings/0001193125-24-139476.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-139476 |
| 2024-05-07 | 16:13 ET | [10-Q](/filings/0000950170-24-054497.md) | Quarterly report, period 2024-03-31 | 0000950170-24-054497 |
| 2024-05-07 | 16:05 ET | [8-K](/filings/0001171843-24-002612.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002612 |
| 2024-04-29 | 16:00 ET | [DEF 14A](/filings/0001193125-24-122181.md) | Proxy statement, period 2024-06-27 | 0001193125-24-122181 |
| 2024-03-12 | 16:15 ET | [10-K](/filings/0000950170-24-029953.md) | Annual report, period 2023-12-31 | 0000950170-24-029953 |
| 2024-03-12 | 16:06 ET | [8-K](/filings/0001171843-24-001294.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001294 |
| 2024-02-28 | 17:28 ET | [8-K](/filings/0001193125-24-050987.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-050987 |
| 2024-02-08 | 17:44 ET | [SC 13D/A](/filings/0001193125-24-028548.md) | Ownership report, active investor, amended | 0001193125-24-028548 |
| 2024-01-25 | 06:06 ET | [8-K](/filings/0001193125-24-014769.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-014769 |
| 2023-11-22 | 16:05 ET | [8-K](/filings/0001193125-23-282236.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-282236 |
| 2023-11-15 | 16:01 ET | [8-K](/filings/0001193125-23-277877.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-277877 |
| 2023-11-06 | 16:05 ET | [SC 13D](/filings/0001193125-23-271361.md) | Ownership report, active investor | 0001193125-23-271361 |
| 2023-11-02 | 16:23 ET | [10-Q](/filings/0000950170-23-058256.md) | Quarterly report, period 2023-09-30 | 0000950170-23-058256 |
| 2023-11-02 | 16:05 ET | [8-K](/filings/0001171843-23-006671.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006671 |

Page 1 of 2. [Older](/companies/algs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.